How to clarify the Baveno VI criteria for ruling out varices needing treatment by noninvasive tests
Author:
Affiliation:
1. Hepatology department; University Hospital; Angers France
2. Department of Medical and Surgical Sciences; University of Bologna; Bologna Italy
Publisher
Wiley
Subject
Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13945/fullpdf
Reference9 articles.
1. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension;De Franchis;J Hepatol,2015
2. Identifying Compensated Advanced Chronic Liver Disease: When (Not) to Start Screening for Varices and Clinically Significant Portal Hypertension
3. Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy;Bae;Liver Int,2018
4. Large esophageal varice screening by a sequential algorithm using a cirrhosis blood test and optionally capsule endoscopy;Cales;Liver Int,2018
5. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease;Colecchia;J Hepatol,2018
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorder;Hepatology;2024-07-02
2. Spleen Stiffness–Based Algorithms Are Superior to Baveno VI Criteria to Rule Out Varices Needing Treatment in Patients With Advanced Chronic Liver Disease;American Journal of Gastroenterology;2024-03-20
3. A pragmatic strategy for the screening and treatment of portal hypertension in patients needing systemic treatment for advanced hepatocellular carcinoma;Digestive and Liver Disease;2023-08
4. Individual and population screening of varices needing treatment by a simple, safe and accurate test;Clinics and Research in Hepatology and Gastroenterology;2023-05
5. MELD score < 18 rule out 28‐day ACLF development among inpatients with hepatitis B‐related previous compensated liver disease;Journal of Viral Hepatitis;2022-09-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3